PharmiWeb Today Story
Lund, Sweden, 24 April 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately. Søren Tulstrup will be stepping down from his position by mutual agreement as CEO after seven years of dedicated service to the Company.
“On behalf of the Board of Directors, I would like to extend our gratitude to Søren for his leadership and significant contribution to the company during his tenure. Under his guidance, Hansa has evolved from a clinical-stage company into a commercial-stage biopharmaceutical organization, navigating both transformative progress and substantial challenges. We deeply appreciate Søren’s commitment to the Company and wish him every success in his future endeavors,” said Peter Nicklin, Chairman of the Board, Hansa Biopharma. “With the appointment of Renée as CEO, Hansa is entering a new phase of growth and development. Renée brings extensive experience in both the biopharmaceutical and financial sectors, and her proven leadership will be instrumental in advancing the Company’s strategic positioning. The Board is confident that she is the right person to successfully lead Hansa through this next chapter, and we look forward to working closely with her.”
Aguiar-Lucander served for seven years as CEO of Calliditas Therapeutics AB where she successfully led the company through a dual listing on NASDAQ in both Sweden and the U.S. During her tenure, the company successfully launched and commercialized the first ever approved drug for immunog…
Read More...
Articles

What Does a Pharmaceutical Account Manager Do?
04-Mar-2025

Top 10 Highest Paying Pharma Jobs in 2025
18-Feb-2025

The Impact of AI on Pharmaceutical Sales
13-Feb-2025

What Does a Medical Science Liaison Do?
18-Sep-2023
Featured Events

-
Next Generation Cancer Vaccine Development Summit…
07-Sep-2021 - 09-Sep-2021 -
1st International Conference “WE! are the Clinical…
18-Sep-2021 - 18-Sep-2021 -
HFpEF Drug Discovery & Development Summit 2022
25-Jan-2022 - 27-Jan-2022 -
Pharmaceutical Manufacturing and Packaging Congres…
20-Jun-2022 - 21-Jun-2022 -
Genomics and Precision Medicine Expo
23-May-2023 - 24-May-2023 -
Global Biomanufacturing Summit
25-May-2023 - 26-May-2023
News

-
IRLAB publishes the Annual Report for 2024
25-Apr-2025 -
Pentixapharm to Present First-in-Class Glycan-Depe…
25-Apr-2025 -
Cantargia Presents Association Between Nadunolimab…
25-Apr-2025 -
Cantargia Presents Promising Preclinical Results o…
25-Apr-2025 -
Exclusive contract for ViroCAP® My Plasma with Lan…
25-Apr-2025 -
Stringent Regulatory Landscape Fuels Robust Growth…
25-Apr-2025